KYNTRA BIO, INC. (KYNB): Nasdaq/NYSE listing notice — Kyntra Bio receives Nasdaq delisting notice for failing $50M assets/revenue rule

KYNTRA BIO, INC.

Received Nasdaq letter on April 2, 2026, for non-compliance with Listing Rule 5450(b)(3)(A) regarding $50M total assets and revenue.
Non-compliance due to FibroGen International revenue reclassified as discontinued operations in 2024-2025.
Company has 45 days (by May 18, 2026) to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
Company may consider transferring to Nasdaq Capital Market as alternative.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

KYNTRA BIO, INC. received a nasdaq deficiency notice notice regarding other (rules 5450(b)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5450(b)(3)(A)

Exact text from the filing

April 2, 2026, Kyntra Bio, Inc. (“Kyntra Bio” or the “Company”) received a letter from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market notifying us that the Company no longer complies with the Nasdaq Global Select Market continued listing requirement of $50 million in total assets and total revenue for the most recently completed fiscal year (or two of the last three most recently completed fiscal years) per Listing Rule 5450(b)(3)(A). This is due to the revenue of FibroGen International being presented as held for sale (in discontinued operations) in 2024 and 2025. The Comp

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

KYNTRA BIO, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-149624

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.